Lazard Capital Starts BG Medicine (BGMD) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts BGMD Hot Sheet
Price: $0.00 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Join SI Premium – FREE
Lazard Capital initiates coverage on BG Medicine (NASDAQ: BGMD) with a Buy. PT $13.
For more ratings news on BG Medicine click here and for the rating history of BG Medicine click here.
Shares of BG Medicine closed at $7.71 yesterday.
For more ratings news on BG Medicine click here and for the rating history of BG Medicine click here.
Shares of BG Medicine closed at $7.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StoneX Starts SoFi Technologies (SOFI) at Buy
- Barclays Starts Eastman Chemical (EMN) at Equalweight
- Cantor Fitzgerald Starts AIR Global (AIIR) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
